How much does Munro Healthcare Group Limited make?

Munro Healthcare Group Limited reported revenue of £78.6m and £1m profit in the year to 31 Mar 2025, according to its accounts filed at Companies House.

How many employees does Munro Healthcare Group Limited have?

Munro Healthcare Group Limited reported an average of 75 employees in the year to 31 Mar 2025.

Is Munro Healthcare Group Limited profitable?

Yes — Munro Healthcare Group Limited reported a profit of £1m in the year to 31 Mar 2025.

Company No. SC417011 · Incorporated 14 Feb 2012

Munro Healthcare Group Limited

Registered name: MUNRO HEALTHCARE GROUP LIMITED

Munro Healthcare Group Limited made £78.6m revenue and £1m profit in the year to 31 Mar 2025. read from filing text

Munro Healthcare Group Limited’s revenue grew 24% to £78.6m in the year to 31 Mar 2025, with £1m profit and 75 employees. The company is classified under “other letting and operating of own or leased real estate” and is based in Glasgow; we hold 4 years of its filed accounts.

Full P&L filedSection L · Real estate activitiesSIC 68209Other letting and operating of own or leased real estate SIC 70100Activities of head offices

Status: Active
Location: Glasgow, Scotland
Age: 14 yrs · since 2012
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Latest accounts · year to 31 Mar 2025

Key figures

Independent

Revenue

£78.6m

Growth ▲23.8%

Profit

£1m

Growth ▼60.4%

Profit margin

1.3%

Gross 10.2%

Employees

Change ▲5.6%

Profit / employee

£13.8k

Revenue/employee £1m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024	31 Mar 2025
Disclosure	Profit only	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	—	£74.3m	£63.5m	£78.6m
Cost of sales	—	£67.8m	£55.1m	£70.6m
Gross profit	—	£6.5m	£8.4m	£8m
Operating profit	—	£1.7m	£2.4m	£1.9m
Profit before tax	—	£1.4m	£3.2m	£1.6m
Profit after tax	£163k	£1.2m	£2.6m	£1m
Profit (best available)	£163k	£1.2m	£2.6m	£1m
Employees (average)	111	60	71	75
Ratios
Profit margin	—	1.7%	4.1%	1.3%
Gross margin	—	8.8%	13.3%	10.2%
Revenue per employee	—	£1.2m	£894k	£1m
Profit per employee	£1.5k	£20.6k	£36.7k	£13.8k
Growth (year on year)
Revenue growth	—	—	▼14.5%	▲23.8%
Profit growth	—	▲659%	▲111.1%	▼60.4%
Headcount growth	—	▼46%	▲18.3%	▲5.6%
Balance sheet — indirect signals, not revenue
Cash at bank	£5.2m	£6.8m	£7.5m	£7.7m
Net assets	£20.7m	£20.9m	£22.8m	£22.3m
Fixed assets	£16.6m	£16.6m	£17.5m	£17.5m
Current assets	£9.9m	£10.1m	£11.1m	£10.6m
Debtors	£0	£15.6k	£46.2k	£12.2k
Deferred income	£49.2k	£65.1k	£280k	£297k
Source	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: 1.3%; Profit ÷ revenue.
Gross margin: 10.2%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1m; Revenue ÷ average employees.
Profit per employee: £13.8k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 22.3%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 0.4%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 0%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼2%; Now £22.3m
Cash at bank: ▲3%; Now £7.7m
Headcount: ▲6%; Now 75
Deferred income: ▲6%; Now £297k
Fixed assets: 0%; Now £17.5m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Subsidiaries (4)

Ecosse Hospital Products LimitedFigures not disclosed
Munro Healthcare Pharma LimitedFigures not disclosed
Newco Pharma LimitedFigures not disclosed
SPL (2010) LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £1m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.